Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2015 (2015), Article ID 139465, 12 pages
http://dx.doi.org/10.1155/2015/139465
Clinical Study

Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial

1L. Sacco Hospital, 20157 Milano, Italy
2Italian Institute of Telemedicine, Solbiate Arno, 21048 Varese, Italy
3Istituto Auxologico Italiano and University of Milano-Bicocca, 20149 Milano, Italy

Received 15 April 2015; Revised 25 June 2015; Accepted 2 July 2015

Academic Editor: Francesco Cappuccio

Copyright © 2015 Ettore Malacco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Lawes, S. V. Hoorn, and A. Rodgers, “Global burden of blood-pressure-related disease, 2001,” The Lancet, vol. 371, no. 9623, pp. 1513–1518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Turnbull and Blood Pressure Lowering Treatment Trialists' Collaboration, “Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials,” The Lancet, vol. 362, no. 9395, pp. 1527–1535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Mancia, R. Fagard, K. Narkiewicz et al., “2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Blood Pressure, vol. 23, no. 1, pp. 3–16, 2014. View at Publisher · View at Google Scholar
  4. The Heart Outcome Prevention Evaluation Study Investigators, “Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients,” The New England Journal of Medicine, vol. 342, pp. 145–153, 2000. View at Google Scholar
  5. PROGRESS Collaborative Study Group, “Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack,” The Lancet, vol. 358, no. 9287, pp. 1033–1041, 2001. View at Publisher · View at Google Scholar
  6. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, “Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium canne blocker vs diuretic: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT),” The Journal of the American Medical Association, vol. 288, no. 23, pp. 2981–2997, 2002. View at Publisher · View at Google Scholar
  7. B. Dahlöf, P. S. Sever, N. R. Poulter et al., “Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial,” The Lancet, vol. 366, no. 9489, pp. 895–906, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Wald, M. Law, J. K. Morris, J. P. Bestwick, and N. J. Wald, “Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials,” The American Journal of Medicine, vol. 122, no. 3, pp. 290–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Law, N. J. Wald, J. K. Morris, and R. E. Jordan, “Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials,” British Medical Journal, vol. 326, no. 7404, article 1427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Waeber, “Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.,” Expert Review of Cardiovascular Therapy, vol. 1, no. 1, pp. 43–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Ambrosioni, “Defining the role of zofenopril in the management of hypertension and ischemic heart disorders,” American Journal of Cardiovascular Drugs, vol. 7, no. 1, pp. 17–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Borghi, S. Bacchelli, and D. D. Esposti, “Long-term clinical experience with zofenopril,” Expert Review of Cardiovascular Therapy, vol. 10, no. 8, pp. 973–982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Borghi, E. Ambrosioni, S. Omboni et al., “Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study,” Journal of Hypertension, vol. 31, no. 6, pp. 1256–1264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Borghi, S. Bacchelli, D. D. Esposti, A. Bignamini, B. Magnani, and E. Ambrosioni, “Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension,” American Journal of Hypertension, vol. 12, no. 7, pp. 665–672, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Nilsson, “Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension,” Blood Pressure, vol. 2, pp. 25–30, 2007. View at Google Scholar · View at Scopus
  16. Y. Lacourciere and P. Provencher, “Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension,” British Journal of Clinical Pharmacology, vol. 27, no. 3, pp. 371–376, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Farsang, “Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients,” Blood Pressure, vol. 16, supplement 2, pp. 19–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-M. Mallion, “An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension,” Blood Pressure, vol. 16, no. 2, supplement, pp. 13–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Malacco, S. Piazza, and S. Omboni, “Zofenopril versus lisinopril in the treatment of essential hypertension in elderly patients: a randomised, double-blind, multicentre study,” Clinical Drug Investigation, vol. 25, no. 3, pp. 175–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Narkiewicz, “Comparison of home and office blood pressure in hypertensive patients treated with zofenopril or losartan,” Blood Pressure, vol. 2, supplement, pp. 7–12, 2007. View at Google Scholar · View at Scopus
  21. G. Leonetti, A. Rappelli, and S. Omboni, “A similar 24-h blood pressure control is obtained by zofenopril and candesartan in primary hypertensive patients,” Blood Press, vol. 15, supplement 1, pp. 18–26, 2006. View at Google Scholar
  22. S. Omboni, E. Malacco, and G. Parati, “Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions,” Cardiovascular Therapeutics, vol. 27, no. 4, pp. 275–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Zanchetti, G. Parati, and E. Malacco, “Zofenopril plus hydrochlorothiazide: combination therapy for the treatment of mild to moderate hypertension,” Drugs, vol. 66, no. 8, pp. 1107–1115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. N. Rogoza, T. S. Pavlova, and M. V. Sergeeva, “Validation of A and D UA-767 device for the self-measurement of blood pressure,” Blood Pressure Monitoring, vol. 5, no. 4, pp. 227–231, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Palatini, G. Frigo, O. Bertolo, E. Roman, R. Da Cortà, and M. Winnicki, “Validation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects' characteristics,” Blood Pressure Monitoring, vol. 3, no. 4, pp. 255–260, 1998. View at Google Scholar · View at Scopus
  26. MOREPRESS website, MOnitoring REmotely blood PRESSure, http://www.morepress.net/.
  27. S. T. Reeves, K. E. Glas, H. Eltzschig et al., “Guidelines for performing a comprehensive epicardial echocardiography examination: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists,” Journal of the American Society of Echocardiography, vol. 20, no. 4, pp. 427–437, 2007. View at Publisher · View at Google Scholar
  28. R. B. Devereux, P. N. Casale, P. Kligfield et al., “Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy,” The American Journal of Cardiology, vol. 57, no. 15, pp. 1388–1393, 1986. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Du Bois and E. F. Du Bois, “A formula to estimate the approximate surface area if height and weight be known. 1916,” Nutrition, vol. 5, no. 5, pp. 303–311, 1989. View at Google Scholar · View at Scopus
  30. J. H. Stein, C. E. Korcarz, and W. S. Post, “Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: summary and discussion of the american society of echocardiography consensus statement,” Preventive Cardiology, vol. 12, no. 1, pp. 34–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Mancia, G. De Backer, A. Dominiczak et al., “2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Journal of Hypertension, vol. 25, pp. 1105–1187, 2007. View at Google Scholar
  32. G. Parati, S. Omboni, E. Malacco et al., “Antihypertensive efficacy of zofenopril and hydrochlorothiazide combination on ambulatory blood pressure,” Blood Pressure, vol. 15, supplement 1, pp. 7–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Bramlage, “Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension,” Vascular Health and Risk Management, vol. 5, pp. 213–224, 2009. View at Google Scholar · View at Scopus
  34. E. Agabiti-Rosei, A. Manolis, D. Zava, and S. Omboni, “Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients,” Advances in Therapy, vol. 31, no. 2, pp. 217–233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Parati, S. Omboni, P. Palatini et al., “Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours,” High Blood Pressure & Cardiovascular Prevention, vol. 15, no. 4, pp. 283–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. D. A. Sica, “Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats,” Drugs, vol. 62, no. 3, pp. 443–462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Schrader, P. Bramlage, S. Lüders, M. Thoenes, A. Schirmer, and D. W. Paar, “BP goal achievement in patients with uncontrolled hypertension: results of the treat-to-target post-marketing survey with irbesartan,” Clinical Drug Investigation, vol. 27, no. 11, pp. 783–796, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. N.-L. Sun, S. Jing, and J. Chen, “The control rate of irbesartan/hydrochlorothiazide combination regimen in the treatment of Chinese patients with mild to moderate hypertension,” Zhonghua Xin Xue Guan Bing Za Zhi, vol. 33, no. 7, pp. 618–621, 2005. View at Google Scholar · View at Scopus
  39. G. Bobrie, J. Delonca, C. Moulin, A. Giacomino, N. Postel-Vinay, and R. Asmar, “A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations,” American Journal of Hypertension, vol. 18, no. 11, pp. 1482–1488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. Neutel, E. Saunders, G. L. Bakris et al., “The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial,” Journal of Clinical Hypertension, vol. 7, no. 10, pp. 578–586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Coca, C. Calvo, J. García-Puig et al., “A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL study,” Clinical Therapeutics, vol. 24, no. 1, pp. 126–138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Lacourcière, “A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged 65 years with mild to moderate hypertension,” Clinical Therapeutics, vol. 22, no. 10, pp. 1213–1224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. K. R. Chiou, C. H. Chen, P. Y. Ding et al., “Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension,” Zhonghua Yi Xue Za Zhi, vol. 63, pp. 368–376, 2000. View at Google Scholar
  44. A. Mimran, L. Ruilope, L. Kerwin et al., “A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension,” Journal of Human Hypertension, vol. 12, no. 3, pp. 203–208, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Angulo, N. R. Robles, J. Grois, A. Barquero, and M. Pérez Miranda, “Comparison of the antihypertensive activity of fosinopril and irbesartan,” Anales de Medicina Interna, vol. 19, pp. 571–575, 2002. View at Google Scholar
  46. R. Kunz, C. Friedrich, M. Wolbers, and J. F. E. Mann, “Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease,” Annals of Internal Medicine, vol. 148, no. 1, pp. 30–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Forni, G. Wuerzner, M. Pruijm, and M. Burnier, “Long-term use and tolerability of irbesartan for control of hypertension,” Integrated Blood Pressure Control, vol. 4, pp. 17–26, 2011. View at Publisher · View at Google Scholar